共 132 条
[1]
Hermans JJ(1993)Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics Br J Pharmacol 110 482-490
[2]
Thijssen HH(1997)Human P450 metabolism of warfarin Pharmacol Ther 73 67-74
[3]
Kaminsky LS(1997)Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers Biochem Pharmacol 54 1195-1203
[4]
Zhang ZY(1998)Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes Clin Pharmacol Ther 63 519-528
[5]
Yamazaki H(2003)Population differences in Clin Pharmacol Ther 73 253-263
[6]
Shimada T(2001)-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients Clin Pharmacol Ther 70 159-164
[7]
Takahashi H(2002)Interindividual variability in sensitivity to warfarin—nature or nurture? Clin Pharmacol Ther 72 702-710
[8]
Kashima T(2004)Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance Pharmacogenetics 14 539-547
[9]
Nomizo Y(2008)Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype Clin Pharmacokinet 47 565-594
[10]
Muramoto N(2008)Pharmacogenetics of oral anticoagulants: a basis for dose individualization Pharmacotherapy 28 1084-1097